<DOC>
	<DOCNO>NCT01287325</DOCNO>
	<brief_summary>This study evaluate efficacy safety two week treatment DNK333 patient COPD cough .</brief_summary>
	<brief_title>Efficacy DNK333 Patients With COPD Cough</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Mild moderate COPD Forced expiratory volume 1 second ( FEV1 ) â‰¥30 % predict FEV1/FVC ( force vital capacity ) &lt; 70 % Significant amount cough minimal amount sputum production , judge self report Exclusion criterion : Upper low airway infection within 4 week prior screen COPD exacerbation within 4 week prior screen Past history current diagnosis congestive heart failure , cirrhosis hepatic failure History lung cancer pulmonary resection/thoracic radiotherapy Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Chronic obstructive pulmonary disease</keyword>
	<keyword>Cough</keyword>
	<keyword>DNK333</keyword>
</DOC>